Biolog completed the acquisition of MIDI.

Biolog, a company in phenotypic cell profiling, metabolic characterization, and microbial identification, completed the acquisition of MIDI, a company in microbial identification. Financial terms were not disclosed. “Combining the technologies from Biolog and MIDI will allow us to offer polyphasic analysis to customers doing any type of microbial ID or phenotypic metabolic profiling to enable a direct link between genotype, phenotype, and proteomics,” Robert Wicke, Biolog CEO.